Testing effectiveness (Phase 2)Ended earlyNCT01353222What this trial is testingDN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial CarcinomaWho this might be right forUrothelial Carcinoma Dendreon 142
Early research (Phase 1)Active Not RecruitingNCT04963153What this trial is testingTesting Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and ImmunotherapyWho this might be right forLocally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis Urothelial CarcinomaLocally Advanced Ureter Urothelial Carcinoma+17 more National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT01326871What this trial is testingALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial CancerWho this might be right forTransitional Cell Carcinoma of BladderUrethra CancerUreter Cancer+1 more Altor BioScience 68
Large-scale testing (Phase 3)Study completedNCT03474107What this trial is testingEvaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)Who this might be right forUreteral CancerUrothelial CancerBladder Cancer Astellas Pharma Global Development, Inc. 608
Not applicableUnknownNCT04391790What this trial is testingMOdified Urinary Conduit to Lower Strictures After radIcal CystectomyWho this might be right forBladder Cancer Jørgen Bjerggaard Jensen 300
Testing effectiveness (Phase 2)WithdrawnNCT05687721What this trial is testingCopanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder CancerWho this might be right forAdvanced Urothelial Carcinoma VA Office of Research and Development
Testing effectiveness (Phase 2)Study completedNCT03219333What this trial is testingEnfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder CancerWho this might be right forCarcinoma, Transitional CellUrinary Bladder NeoplasmsUrologic Neoplasms+4 more Astellas Pharma Inc 219
Testing effectiveness (Phase 2)Looking for participantsNCT05756569What this trial is testingEnfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant HistologyWho this might be right forBladder Squamous Cell CarcinomaLocally Advanced Bladder CarcinomaMalignant Renal Pelvis Neoplasm+8 more Emory University 25
Testing effectiveness (Phase 2)Study completedNCT02438865What this trial is testingProphylactic Intravesical Chemotherapy After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: a Randomized Controlled Trial Between Single Postoperative Dose Versus Maintenance Therapy.Who this might be right forNeoplasm, UreterNeoplasm, Bladder Mansoura University 74
Not applicableUnknownNCT05739812What this trial is testingThe Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological TelesurgeryWho this might be right forRenal Cell CarcinomaAdrenal TumorNonfunctioning Kidney+11 more The Affiliated Hospital of Qingdao University 100
Testing effectiveness (Phase 2)Study completedNCT02665039What this trial is testingA Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal FunctionWho this might be right forUrothelial CarcinomaBladder CancerRenal Pelvis Cancer+2 more Dr Anders Ullén 62
Early research (Phase 1)Active Not RecruitingNCT02496208What this trial is testingCabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary TumorsWho this might be right forBladder Small Cell Neuroendocrine CarcinomaBladder Squamous Cell CarcinomaBladder Urothelial Carcinoma+27 more National Cancer Institute (NCI) 152
Not applicableStudy completedNCT02430779What this trial is testingIrreversible Electroporation(IRE) For Unresectable Renal Pelvic and Ureteral NeoplasmsWho this might be right forRenal Pelvic and Ureteral Neoplasms Fuda Cancer Hospital, Guangzhou 30
Testing effectiveness (Phase 2)Study completedNCT01282463What this trial is testingStudy of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis CarcinomaWho this might be right forCarcinoma of Urinary TractUrethral CarcinomaCarcinoma of Ureter+1 more Eli Lilly and Company 148
Not applicableStudy completedNCT04028479What this trial is testingThe Registry of Oncology Outcomes Associated With Testing and TreatmentWho this might be right forAdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more Taproot Health 167
Not applicableLooking for participantsNCT05992363What this trial is testingTandem Polyurethane Stents Compared to Single Silicone Stent for Malignant Ureteral ObstructionWho this might be right forHydronephrosis; Obstruction, UreterRenal FailureMalignancy+2 more Rabin Medical Center 106
Post-approval studies (Phase 4)Looking for participantsNCT06709196What this trial is testingClinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric ProphylaxisWho this might be right forCystectomyBladder Cancer Requiring CystectomyPostoperative Infections+2 more Rigshospitalet, Denmark 248
Not applicableStudy completedNCT04594161What this trial is testingEffectiveness of Drainage by PCN vs. JJ in Patients With Symptoms of Obstructive Kidney Disease Caused by UrolithiasisWho this might be right forUrolithiasisUrologic DiseasesUrinary Calculi+30 more Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 204
Early research (Phase 1)Study completedNCT01182168What this trial is testingGemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor MalignanciesWho this might be right forBladder CancerRenal Pelvis CancerUreter Cancer Memorial Sloan Kettering Cancer Center 12
Large-scale testing (Phase 3)Active Not RecruitingNCT03244384What this trial is testingTesting MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial CancerWho this might be right forLocalized Renal Pelvis and Ureter Urothelial CarcinomaLocally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis and Ureter Urothelial Carcinoma+8 more National Cancer Institute (NCI) 739